Month: September 2021

NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail. The shareholders of ZetaDisplay AB (publ) reg. no. 556603-4434 (the “Company” or “ZetaDisplay”) are hereby given notice of the Extraordinary General Meeting (the “EGM”) to be held on 7 October 2021. Due to the extraordinary situation relating to the covid-19 pandemic, the ZetaDisplay’s EGM will be carried out through advance voting (postal voting) pursuant to temporary legislation. There will be no meeting with the possibility to attend in person or to be represented by a proxy. ZetaDisplay welcomes all shareholders to exercise their voting rights at the EGM through advance voting as described below. Information on the resolutions passed at the EGM will be published on 7 October 2021 as soon as the result...

Novozymes launches the natural and biodegradable detergent ingredient Pristine® to address some of the biggest unsolved consumer challenges within the laundry category. This ground-breaking enzyme tackles malodor and discoloration at the very source, setting a new threshold for detergent performance. COPENHAGEN, Denmark – September 15, 2021 – Every day, people all over the world wash their clothes in an effort to remove odors. In addition to the stains we pick up on our clothes, there is also an invisible mix of residual skin cells, sebum, soils, and sweat (called body grime) that builds in layers on our fabrics causing persistent malodor and discoloration – challenges that today’s traditional detergents have yet to solve.“For years, Novozymes has been at the forefront of exploring laundry benefits beyond stain removal and with...

In August, “Novaturas” group operated flights from Lithuania, Latvia, and Estonia to Turkey, Greek islands, Bulgaria, and Montenegro. During August, the company served 26.4 thousand customers. Group revenue in August amounted to EUR 15.3 million. In total, during January – August, the company served 98.7 thousand customers – 138% more than in the same period last year and 51% less than the corresponding time in 2019. Cumulative January – August turnover reached EUR 59.5 million and was 106% more and 49% lower than the corresponding time last year and in 2019.  “The results of the first and second months of the third quarter are almost identical. Group-wide, we have served more than 26 thousand travelers and generated more than EUR 15 million revenues each month. While planning this summer season, we have foreseen...

NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. CHICAGO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (Nasdaq: MDLZ) (“Mondelēz International” or the “Guarantor”) announces today that its fully-owned subsidiary Mondelez International Holdings Netherlands B.V. (the “Issuer”) has launched an offering (the “Offering”) of approximately EUR 300 million of senior unsecured bonds (the “Bonds”), fully and unconditionally guaranteed (the “Guarantee” and together with the Bonds, the “Securities”) by the Guarantor, exchangeable into existing ordinary shares in the capital of JDE Peet’s N.V. (Euronext Amsterdam: JDEP) a public limited liability company (naamloze vennootschap)...

The independent DMC (Data Monitoring Committee) recommends continuation of Part 2 of the Phase 2-3 Study (“the COVA Study”) without any protocol amendment The second Interim Analysis (“IA2”) based on 155 hospitalized patients shows no futility, with efficacy results in the promising zone, indicating that BIO101 remains a candidate treatment for acute respiratory failure associated with COVID-19 To date, 200 patients have been enrolled in COVA study and 15 additional sites in USA, Brazil, France, UK and Belgium will be opened to accelerate patient recruitment and report top line results depending on the evolution of the pandemic in Q1 2022PARIS and CAMBRIDGE, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development...

Incap Corporation                                                Stock Exchange ReleaseInside information                                      15 September 2021 at 08:30 a.m. (EEST) Incap Corporation: Incap increases its revenue and operating profit estimate for 2021 Incap estimates that its revenue, operating profit (EBIT) and adjusted operating profit (EBIT) for 2021 will be significantly higher than in 2020. The increase in the revenue and operating profit estimate is driven by improved visibility related to the customers’ forecasts and the company’s own assessments of the business development. The estimates are given provided that there are no major negative changes in the coronavirus pandemic situation, currency exchange rates or in component availability. Previously the company estimated that its revenue, operating...

Collaboration marks first step in evaluating the potential of the rapidly growing theranostics market Louvain-La-Neuve, Belgium, 15 September 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) today announce a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer. New perspectives in the treatment of cancerNuclear medicine has evolved considerably over recent years with the emergence of radiotheranostics, a modality which combines targeted diagnosis and therapy with radio-isotopes, offering an important alternative in the treatment of many cancers. Radiotheranostics is based on the use of radio-isotopes which, when they disintegrate,...

Roche launches the Digital Pathology Open Environment, encouraging collaboration among software developers to improve patient outcomes and expand personalised healthcare through innovative image analysis tools Artificial intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment Open digital pathology environments can break down barriers to allow for rapid technology advances across industry and research partners, which is critical in developing next-generation diagnostic testsBasel, 15 September 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche’s...

OSLO, Norway (15 September 2021) – CFO Sven Børre Larsen will present at Pareto Securities’ 28th energy conference in Oslo today. Please find the presentation attached. About TGSTGS provides scientific data and intelligence to companies active in the energy sector. In addition to a global, extensive and diverse energy data library, TGS offers specialized services such as advanced processing and analytics alongside cloud-based data applications and solutions. Forward Looking StatementAll statements in this press release other than statements of historical fact are forward-looking statements, which are subject to a number of risks, uncertainties and assumptions that are difficult to predict, and are based upon assumptions as to future events that may not prove accurate. These factors include TGS’ reliance on a cyclical industry and...

First data set from lacutamab TELLOMAK trial demonstrated encouraging 35% overall global response rate, including skin improvement in patients with mycosis fungoides that express KIR3DL2 New pre-clinical data presented from next-generation NK cell engager platform, ANKET™, highlighted robust anti-tumor efficacy across several in vivo tumor models and manageable safety profile Cash position of €159.4 million1 as of June 30, 2021 Conference call to be held today at 2:00 p.m. CEST / 8:00 a.m. EDTMARSEILLE, France, Sept. 15, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its consolidated financial results for the six months ended June 30, 2021. The consolidated financial statements are attached to this press release. “In the first half of 2021, we had two key...